Radiomics in Lung Metastases: A Systematic Review

Overview

Journal J Pers Med

Date 2023 Feb 25

PMID 36836460

Authors

Michela Gabelloni

Lorenzo Faggioni

Roberta Fusco

Igino Simonetti

Federica De Muzio

Giuliana Giacobbe

Alessandra Borgheresi

Federico Bruno

Diletta Cozzi

Francesca Grassi

Mariano Scaglione

Andrea Giovagnoni

Antonio Barile

Vittorio Miele

Nicoletta Gandolfo

Vincenza Granata

Affiliations

Soon will be listed here.

Abstract

Due to the rich vascularization and lymphatic drainage of the pulmonary tissue, lung metastases (LM) are not uncommon in patients with cancer. Radiomics is an active research field aimed at the extraction of quantitative data from diagnostic images, which can serve as useful imaging biomarkers for a more effective, personalized patient care. Our purpose is to illustrate the current applications, strengths and weaknesses of radiomics for lesion characterization, treatment planning and prognostic assessment in patients with LM, based on a systematic review of the literature.

Citing Articles

Retrospective Analysis Comparing Lung-RADS v2022 and British Thoracic Society Guidelines for Differentiating Lung Metastases from Primary Lung Cancer.

Stana L, Mederle A, Avram C, Bratosin F, Barata P Biomedicines. 2025; 13(1.

PMID: 39857714 PMC: 11762811. DOI: 10.3390/biomedicines13010130.

Clinical features and risk of multiple primary malignancies after endoscopic treatment in patients with early esophageal squamous cell carcinoma: a retrospective cohort study.

Liu H, Zhang Q, Zhang S, Zhang Y, Song R, Li P J Gastrointest Oncol. 2024; 15(4):1386-1398.

PMID: 39279981 PMC: 11399870. DOI: 10.21037/jgo-24-299.

Fusion of shallow and deep features from F-FDG PET/CT for predicting EGFR-sensitizing mutations in non-small cell lung cancer.

Yao X, Zhu Y, Huang Z, Wang Y, Cong S, Wan L Quant Imaging Med Surg. 2024; 14(8):5460-5472.

PMID: 39144023 PMC: 11320501. DOI: 10.21037/qims-23-1028.

Artificial intelligence-based application in multiple myeloma.

Piscopo L, Scaglione M, Klain M Eur J Nucl Med Mol Imaging. 2024; 51(7):1923-1925.

PMID: 38587646 DOI: 10.1007/s00259-024-06711-z.

Transfer-Learning Deep Radiomics and Hand-Crafted Radiomics for Classifying Lymph Nodes from Contrast-Enhanced Computed Tomography in Lung Cancer.

Laqua F, Woznicki P, Bley T, Schoneck M, Rinneburger M, Weisthoff M Cancers (Basel). 2023; 15(10).

PMID: 37345187 PMC: 10216416. DOI: 10.3390/cancers15102850.

References

Gao W, Wang W, Song D, Yang C, Zhu K, Zeng M . A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma. Radiol Med. 2022; 127(3):259-271. DOI: 10.1007/s11547-021-01445-6. View

Wang F, Zheng H, Li J, Li P, Zheng C, Chen Q . Prediction of recurrence-free survival and adjuvant therapy benefit in patients with gastrointestinal stromal tumors based on radiomics features. Radiol Med. 2022; 127(10):1085-1097. DOI: 10.1007/s11547-022-01549-7. View

Kirienko M, Cozzi L, Rossi A, Voulaz E, Antunovic L, Fogliata A . Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions. Eur J Nucl Med Mol Imaging. 2018; 45(10):1649-1660. DOI: 10.1007/s00259-018-3987-2. View

Zhong F, Liu Z, An W, Wang B, Zhang H, Liu Y . Radiomics Study for Discriminating Second Primary Lung Cancers From Pulmonary Metastases in Pulmonary Solid Lesions. Front Oncol. 2022; 11:801213. PMC: 8761898. DOI: 10.3389/fonc.2021.801213. View

Lee Y, Tan Y, Oon C . Molecular targeted therapy: Treating cancer with specificity. Eur J Pharmacol. 2018; 834:188-196. DOI: 10.1016/j.ejphar.2018.07.034. View

Halefoglu A, Ozagari A . Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon. Radiol Med. 2021; 126(9):1139-1148. DOI: 10.1007/s11547-021-01350-y. View

Falcinelli L, Mendichi M, Chierchini S, Tenti M, Bellavita R, Saldi S . Pulmonary function in stereotactic body radiotherapy with helical tomotherapy for primary and metastatic lung lesions. Radiol Med. 2020; 126(1):163-169. DOI: 10.1007/s11547-020-01223-w. View

Tagliafico A, Bignotti B, Torri L, Rossi F . Sarcopenia: how to measure, when and why. Radiol Med. 2022; 127(3):228-237. PMC: 8960583. DOI: 10.1007/s11547-022-01450-3. View

Schlachtenberger G, Doerr F, Menghesha H, Lauinger P, Wolber P, Sabashnikov A . Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review. Medicina (Kaunas). 2022; 58(8). PMC: 9332790. DOI: 10.3390/medicina58081000. View

10.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View

11.

Gerull W, Puri V, Kozower B . The epidemiology and biology of pulmonary metastases. J Thorac Dis. 2021; 13(4):2585-2589. PMC: 8107531. DOI: 10.21037/jtd.2020.04.28. View

12.

Neri E, Gabelloni M, Bauerle T, Beets-Tan R, Caruso D, DAnastasi M . Involvement of radiologists in oncologic multidisciplinary team meetings: an international survey by the European Society of Oncologic Imaging. Eur Radiol. 2020; 31(2):983-991. PMC: 7813742. DOI: 10.1007/s00330-020-07178-w. View

13.

Alix-Panabieres C, Pantel K . Liquid Biopsy: From Discovery to Clinical Application. Cancer Discov. 2021; 11(4):858-873. DOI: 10.1158/2159-8290.CD-20-1311. View

14.

Palatresi D, Fedeli F, Danti G, Pasqualini E, Castiglione F, Messerini L . Correlation of CT radiomic features for GISTs with pathological classification and molecular subtypes: preliminary and monocentric experience. Radiol Med. 2022; 127(2):117-128. DOI: 10.1007/s11547-021-01446-5. View

15.

Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

16.

Li Z, Chen G, Ding L, Wang Y, Zhu C, Wang K . Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions. Mol Ther. 2019; 27(12):2100-2110. PMC: 6904825. DOI: 10.1016/j.ymthe.2019.08.008. View

17.

Digumarthy S, Mendoza D, Padole A, Chen T, Peterson P, Piotrowska Z . Diffuse Lung Metastases in -Mutant Non-Small Cell Lung Cancer. Cancers (Basel). 2019; 11(9). PMC: 6769768. DOI: 10.3390/cancers11091360. View

18.

Sarkar B, Ganesh T, Munshi A, Manikandan A, Roy S, Krishnankutty S . Rotational positional error-corrected linear set-up margin calculation technique for lung stereotactic body radiotherapy in a dual imaging environment of 4-D cone beam CT and ExacTrac stereoscopic imaging. Radiol Med. 2021; 126(7):979-988. DOI: 10.1007/s11547-021-01355-7. View

19.

Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pelle E . Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol. 2018; 10:1758835918794630. PMC: 6116068. DOI: 10.1177/1758835918794630. View

20.

Park J, Kim D, Kim H, Park S, Kim J, Cho S . Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement. Eur Radiol. 2019; 30(1):523-536. DOI: 10.1007/s00330-019-06360-z. View